Sam Beukema Set for Napoli Move As Medical Tests Underway

Sam Beukema is close to joining Napoli, arriving for medical tests before his transfer from Bologna. The defender’s move is expected to finish soon, marking an important addition for the Serie A team.

WHAT HAPPENED?

Napoli and Bologna have agreed on Beukema’s transfer. The deal is worth around €20 million, with possible bonuses associated with performance. Beukema, aged 26, said goodbye to his Bologna teammates and went for his medical tests in Naples. He is set to be a key player in Napoli’s defense after 80 games for Bologna. He helped the team secure a European spot and win the Coppa Italia in the 2024-25 season, showcasing his strength and consistency in defense as Bologna finished ninth in Serie A last season.

WHY NAPOLI WANTED BEUKEMA

Napoli finished the 2024/25 Serie A season as the winners, but struggling with injuries and defense problems even though their lack of European competitions meant they could give their whole focus to the Serie A. Antonio Conte’s second season as coach signals a rebuild for the club. Signing Beukema is an important step due to his Serie A experience and role in Bologna’s strong season, where Bologna gained a historical trophy and Napoli will want to capitalize on the defender’s experience. Beukema’s fast adaptation and stable play convinced Napoli’s management to invest in him. Conte’s team now gets a necessary lift after last year’s injuries to other defenders.

WHAT’S NEXT FOR NAPOLI AND BEUKEMA?

Once Beukema finishes his medicals and signs his contract, he will join Napoli’s pre-season camp for the 2025/26 season. Napoli’s first Serie A match is in mid-August, giving Beukema a few weeks to fit in. Napoli aims to return to European play, while Bologna, who did well under Vincenzo Italiano last season, must fill the gap left by Beukema’s move as they prepare for their Serie A debut. Napoli faces a challenging start against Sassuolo, who were just three points behind them last year, making Beukema’s quick impact crucial.